{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-033750","form_type":"8-K","ticker":"GCTK","cik":"0001506983","company_name":"Glucotrack, Inc.","filed_at":"2022-11-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.914033+00:00","generated_at":"2026-06-21T13:03:46.746704+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"GlucoTrack receives Nasdaq delisting notice for equity deficiency","bullets":["Stockholders' equity was $2,355,000 as of Sept 30, 2022, below Nasdaq's $2,500,000 minimum.","Company has 45 days (until Jan 6, 2023) to submit a compliance plan to Nasdaq.","Failure to regain compliance may lead to delisting of common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-033750","json":"https://secwatch.observer/filing/0001493152-22-033750.json","markdown":"https://secwatch.observer/filing/0001493152-22-033750.md","text":"https://secwatch.observer/filing/0001493152-22-033750.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506983/000149315222033750/0001493152-22-033750-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506983/000149315222033750/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T13:03:46.746704+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"656b8fcf4f7143d87f2ab0ea0c727e45af2cfddf","claim":"Glucotrack, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"November 22, 2022, Nasdaq provided notice that pursuant to Nasdaq Listing Rule 5550(b)(1), GlucoTrack, Inc. (the “Company”) is required to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. Since its 10-Q for the period ended September 30, 2022 reported stockholders’ equity of $2,355,000, and as of November 22, 2022, the Company does not meet the alternatives of market value of listed securities or net income from continuing operations, the Company no longer complies with the Rule. The Company has a 45-day period ending on January 6, 2023 to submit a plan of compli","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1506983/000149315222033750/0001493152-22-033750-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}